Biosimilars Litigation Redux: Amgen Sues Hospira For Terminating Patent Dance
This article was originally published in The Pink Sheet Daily
Executive Summary
Hoping for reversal in Sandoz Zarxio case, Amgen files similar suit against Hospira over failure to provide manufacturing information for Epogen biosimilar.